Jack Jennings, IASIOS Accredited Centre, interview with Interventional News
In response to the question “How will IASIOS benefit your practice?” Jack Jennings from Mallinckrodt Institute of Radiology at Washington University said “Our quality and safety office was very excited to be a part of IASIOS. The application process educated us on some deficiencies and we have already begun making modifications in our patient workflow.”
University Hospital Marburg receives IASIOS Accreditation!
The University Hospital Marburg, led by Prof. Andreas Mahnken achieved the IASIOS accreditation in April 2024; this milestone certifies the facilities commitment to providing innovative minimally invasive cancer care, with its interventional techniques.
Prof. Mahnken comments: “At Marburg University Hospital, cancer patients are treated with state-of-the-art techniques in the Clinic for Diagnostic and Interventional Radiology. This international certification confirms our commitment to tumor patients as therapeutic radiologists. It is an incentive to further develop these innovative technologies in a quality-assured manner.”
Unifying IO globally: IASIOS reports first US-accredited centre
Interventional News, Issue 93
Mallinckrodt Institute of Radiology at Washington University became the first centre in the USA to achieve IASIOS accreditation. In an interview with Interventional News, they relay that the accreditation has strengthened bonds with physicians from international IASIOS centres. The article dives into the development and importance of IASIOS, with quotes from Steering Board members and the Council.
IASIOS at PAIRS 2024
IASIOS attended the PAIRS congress for the first time, bringing a workshop that provided a comprehensive overview of the latest standards and advancements in interventional oncology, broadening the participants’ understanding of the application and accreditation process.
In an article on the CIRSE Insider, they expand on the participation of IASIOS and CIRSE at PAIRS 2024.
A year of milestones and growth for IASIOS
As reported in the CIRSE Insider, 2023 was a year of milestones and growth for IASIOS, with a 135% increase in facility participation.
With the accelerated growth, IASIOS welcomed eight new council members in 2023.
Interventional Oncology Accreditation Programme IASIOS Continues To Reach New Heights
The only accreditation system of its kind has nearly tripled its network of esteemed interventional oncology centres worldwide since launching in 2021.
[Vienna, Austria, August 8, 2023] – The International Accreditation System for Interventional Oncology Services (IASIOS) is taking the world by storm with its exceptional growth and expansion, revolutionizing the landscape of patient care in the field of interventional oncology.
IASIOS, the esteemed membership-based accreditation, is raising the bar for quality assurance in the realm of Interventional Oncology (IO). It’s no wonder that global interventional oncologists are flocking to be a part of this prestigious network, which sets unparalleled standards for excellence in patient care.
Developed to recognize facilities that adhere to the CIRSE Standards of Quality Assurance in Interventional Oncology, IASIOS has become the beacon of quality and trust in the field.
What sets IASIOS apart is its multi-tiered accreditation system. Facilities can earn the Enrolled Seal by actively implementing necessary changes to meet the core criteria required for accreditation. Upon successfully demonstrating compliance with the core criteria through the IASIOS application process, facilities are awarded the prestigious Accredited Seal. For those that go above and beyond to meet both core and extended criteria, the ultimate recognition comes in the form of the Centre of Excellence Seal.
The heart of IASIOS beats strong with its dedicated and renowned Steering Board and Committee. The system is further supported by a network of representatives from leading IO hospitals across the globe adding the touch of collaboration that propels IASIOS to greater heights. Moreover, with support from over 40 interventional radiology societies worldwide, the IASIOS community becomes a formidable force driving advancements in interventional oncology and patient care.
Since its public launch in 2021, IASIOS has experienced exponential growth. Starting with just 12 participating facilities, IASIOS now boasts over 40 facilities. IASIOS Accredited Centre Seals have been awarded to 15 centres from countries spanning Australia, France, Germany, Greece, Italy, Netherlands, Singapore, Switzerland, Turkey, and the UK. Now, in 2023, the excitement reaches a crescendo as IASIOS makes its mark in new territories, welcoming facilities from South America, the USA, the UAE, Belgium and Ireland to its illustrious network.
What truly sets IASIOS apart is its commitment to empowering its member facilities. Through the implementation of the membership annual benefits program, IASIOS offers a plethora of initiatives for career and professional development, networking, mentorship, workshops, promotion, recognition, and valuable survey opportunities. This concerted effort aims to elevate the standard of care for a greater number of cancer patients worldwide.
Enrollment is open for all facilities seeking to embark on a journey of excellence in interventional oncology. Join the movement shaping the future of patient care and become a part of the ever-expanding IASIOS community.
For more information and to get started, visit their website at www.iasios.org or contact the IASIOS team directly at [email protected]. Don’t miss this chance to transform patient care in interventional oncology.
Survey: Compliance With IO Accreditation Standards
Dr Murat DokDok and Dr Huseyin Tugsan Balli evaluated Turkish IRs doctors in an e-survey based on the core criteria from IASIOS Standards of Quality Assurance. Discover their study results in the published article in the Cureus, The Journal of Medical Science. 34 IR doctors responded to the questionnaire, five questions, consisting of 34 articles using 5 points Likert scale. The more experience they have in IR, the more compliance they have with IASIOS criteria.
IO recognition in Australia and New Zealand – Dr. Nick Brown
Interventional News
In an interview with Interventional News, Prof. Nich Brown, an IASIOS Council Member from the Accredited facility I-Med, The Wesley Hospital, emphasized how IOs face challenges getting a seat at Multidisciplinary meetings and how the IASIOS accreditation improves IO recognition.
The Medias Hospital is Raising the Bar for Interventional Oncology as an IASIOS Enrolled Centre
The Medias Hospital has taken the next step in committing to the highest standards in interventional oncology (IO) care and is thrilled to announce its official enrolment in the IASIOS accreditation program. The hospital’s participation reflects on their dedication to staying at the forefront of cancer care.
The University of Turin was awarded the IASIOS accredited centre seal!
“The radiology department at the University of Turin has proudly received the IASIOS accreditation, distinguishing them as one of the top facilities offering minimally invasive procedures to treat cancer. “We are extremely satisfied and proud of this recognition,” comments Dr. Giovanni La Valle, Director General of the City of Health of Turin. “It is a demonstration of the quality of the services that we try to offer every day to cancer patients,” he added
